vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidemiene - lipid modifiserende midler - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
ezetimibe/simvastatin accord 10 mg / 20 mg
accord healthcare b.v. - ezetimib / simvastatin - tablett - 10 mg / 20 mg
ezetimibe/simvastatin accord 10 mg / 40 mg
accord healthcare b.v. - ezetimib / simvastatin - tablett - 10 mg / 40 mg
cholib
viatris healthcare limited - fenofibrate, simvastatin - dyslipidemiene - lipid modifiserende midler - cholib angis som tilleggsbehandling behandling til kosthold og mosjon i høy kardiovaskulær risiko voksne pasienter med blandet dyslipidaemia å redusere triglyserider og øke hdl c nivåer når ldl c nivåer er tilstrekkelig kontrollert med den tilsvarende dosen simvastatin monoterapi.
sovaldi
gilead sciences ireland uc - sofosbuvir - hepatitt c, kronisk - antivirale midler til systemisk bruk - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 og 5. for hepatitt c-virus (hcv) genotypen bestemt aktivitet, se kapittel 4. 4 og 5. sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 og 5. for hepatitt c-virus (hcv) genotypen bestemt aktivitet, se kapittel 4. 4 og 5.
isaderm vet 5 mg/ g / 1 mg/ g
dechra veterinary product a/s - fusidinsyrehemihydrat / betametasonvalerat - gel - 5 mg/ g / 1 mg/ g
stesolid 2 mg
actavis group ptc ehf (1) - diazepam - tablett - 2 mg
stesolid 5 mg
actavis group ptc ehf (1) - diazepam - tablett - 5 mg
vival 5 mg
actavis group ptc ehf (1) - diazepam - tablett - 5 mg
vival 2 mg
actavis group ptc ehf (1) - diazepam - tablett - 2 mg